Modification of the antinociceptive action of aminopyrine by an  -adrenergic blocking agent (phentolamine) and 2  -adrenergic blocking drugs (propranolol, oxoprenolol).
D000433:1-Propanol / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000632:Aminopyrine / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D000818:Animals; D001095:Arachidonic Acids; D004357:Drug Synergism; D008297:Male; D051379:Mice; D010646:Phentolamine / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use*; D013035:Spasm / Q000139:chemically induced / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001095:Arachidonic Acids; D011437:Propylamines; D000632:Aminopyrine; D000433:1-Propanol; D011433:Propranolol; D010646:Phentolamine